- CRS Publications
- News
News
Authors:
Date:
Business Wire: August 10, 2016 – REDWOOD CITY, CA, U.S.A. – Heron Therapeutics, Inc. (NASDAQ: HRTX), today announced that the U.S. Food and Drug Administration (FDA) has approved SUSTOL® (granisetron) extended-release injection. SUSTOL is a serotonin-3 (5-HT3) receptor antagonist indicated in…
Authors:
Date:
Business Wire: August 4, 2016 – JERUSALEM, Israel – Intec Pharma Ltd. (Nasdaq: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™ platform technology, announces the initiation of a new clinical development program for its Accordion…
Authors:
Date:
PRNewswire: August 1, 2016 – MOUNTAIN VIEW, CA, U.S.A. – Based on its recent analysis of the food encapsulation market, Frost & Sullivan recognizes Innovative Food Processors, Inc. (IFP) with the 2016 North America Frost & Sullivan Award for Technology Innovation. IFP’s proprietary PrimeCAP…
Authors:
Date:
PRNewswire: July 20, 2016 – SAN FRANCISCO, CA, U.S.A. – Scientists at Shasqi, Inc. and SUNY University at Albany have published research demonstrating a way to target drugs to specific areas of the body, enabling greater efficacy and fewer side effects. The method, called local drug activation,…
Authors:
Date:
PRNewswire: July 20, 2016 – PHILADELPHIA, PA, U.S.A. – Lannett Company, Inc. (NYSE: LCI) today announced that its strategic partner, Sparsha Pharma USA, Inc., has received an acceptable for filing letter from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA…
Authors:
Date:
Business Wire: July 19, 2016 – PRINCETON, NJ, U.S.A., and PARIS, France – STENTYS (Paris: STNT) (FR0010949404 — STNT), a medical technology company commercializing the world’s first and only Self-Apposing® coronary stent, today announced that it has commenced enrolling patients in the TRUNC trial,…
